SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 688505 for the last quarter is 138.23 M CNY, and it's 46.62% lower compared to the previous quarter. The net income of Q3 24 is 16.00 M CNY.